CMS Open Payments · Program Year 2024
Koya Medical, Inc.
Koya Medical, Inc. reported $37,740.96 across General Payments, Research, and Ownership to 177 physicians and teaching hospitals across 177 transactions.
- $37.7K Below-median payer
- All-tracks total
- 177 Above-median volume
- Transactions
- 177 Above-median reach
- Recipients
- +$24.0K
- General Payments vs PY2023
Koya Medical, Inc. reported $37,740.96 across all CMS Open Payments tracks (General + Research + Ownership) to 177 physicians and teaching hospitals in Program Year 2024 - ranking #1417 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $37,740.96, averaging $213.23 per recipient.
Koya Medical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
11/100
Total payments
F
10/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer koya-medical-inc Koya Medical, Inc.
$37.7K · #1417/1,925 · 0.0% industry · PY2024
- TOT $37.7K
- RANK #1417
- SHARE 0.0%
- TXN 177
- RCP 177
- CAT 1
- GEN $37.7K
- ΔGEN +$24.0K
- TOP1 10.3%
- PY 2024
Volume peers
Nearest volume peer: Laminate Medical Technologies inc. ($37.7K)
Koya Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Koya Medical, Inc.'s CMS-reported General Payments increased by $24.0K (+174.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: KOYA MEDICAL, INC.PY2023: KOYA MEDICAL, INC.PY2024: Koya Medical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $13,773.70
- PY2024
- $37,740.96
What the Data Shows for Koya Medical, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Koya Medical, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $37.7K, accounting for 100.0% of this company's General Payments and 177 transactions.
General Payment Breakdown by Type
Koya Medical, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $37.7K, 100.0% of General Payments.
How Koya Medical, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $37.7K | 177 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $7,375.12 (19.5%) of $37,740.96 in this company's General Payments records across 151 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Koya Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Paula Deanda
$3,900.00 across 1 reported transactions
- 2
Raymond Brickhouse
$1,621.35 across 1 reported transactions
- 3
Reza Khodaverdian
$651.76 across 2 reported transactions
- 4
Sam Ahn
$607.82 across 2 reported transactions
- 5
Neil Goldstein
$594.19 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Koya Medical, Inc.'s spend rank (#1417 of 1,925, bottom 26% by spend) and concentration rank (#1,562 of 1,838, bottom 15% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Painteq LLC : $367.8K total payments, HHI 201
- SPR Therapeutics, Inc : $1.1M total payments, HHI 200
- Envista Holdings Corporation : $6.0M total payments, HHI 200
- Vericel Corporation : $1.3M total payments, HHI 200
- Straumann USA LLC : $7.6M total payments, HHI 200
- Eclipse Technology Solutions Inc. : $47.7K total payments, HHI 199
- Koya Medical, Inc. (this company) : $37.7K total payments, HHI 199
- F. Hoffmann-La Roche AG : $2.5M total payments, HHI 198
- Optinose US, Inc. : $1.3M total payments, HHI 196
- Tonix Medicines, Inc. : $63.3K total payments, HHI 196
- Patterson Companies, Inc. : $1.7M total payments, HHI 194
- Amneal Pharmaceuticals LLC : $1.9M total payments, HHI 194
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Koya Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Koya Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Koya Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Ortho2, LLC
Hydrofera LLC
Arcuro Medical Inc
Sensible Medical Innovations Inc
Phadia AB
Put this to use
Koya Medical, Inc. ranks #1417 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Koya Medical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.